Search Results

CEA and CAS Comparative Effectiveness Evaluated in Medicare Population

April 20, 2012—An evaluation of the comparative effectiveness of carotid revascularization procedures stratified by Medicare age was published March 30 online ahead of print in the Journal of Vascular Surgery by Jeffrey Jim, MD, et al for the Society for Vascular Surgery (SVS) Outcomes Committee.

Silk Road Medical Enroute System Will Be Evaluated in Postmarket ROADSTER 3 Study of TCAR for Standard-Risk Patients

June 15, 2022—Silk Road Medical, Inc. announced a prospective study to evaluate the company’s TCAR system for transcarotid artery revascularization in the treatment of standard surgical risk patients with carotid artery disease.

Silk Road Medical Begins ROADSTER 3 Postapproval Study of TCAR System in Patients at Standard Surgical Risk

September 7, 2022—Silk Road Medical, Inc. announced enrollment of the first patient in the ROADSTER 3 postapproval study of the company’s system for transcarotid artery revascularization (TCAR) of patients at standard surgical risk with carotid artery disease in real-world treatment.

Terumo Aortic’s Fenestrated Treo Abdominal Stent Graft System Granted FDA Breakthrough Device Designation

March 16, 2026—Terumo Aortic announced that the FDA has granted Breakthrough Device designation for the company’s fenestrated Treo abdominal stent graft system.